Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platforms PLEASANTON, Calif., June 17, 2026 /PRNewswire/ -- ...
Shares of TXG advanced 3.8% on Wednesday following the announcement of a strategic research agreement with Cleveland Clinic The partnership targets biomarker identification in bladder cancer utilizing ...
Complete the form below to receive the poster. Spatial transcriptomics technologies vary widely in spatial resolution, sensitivity and compatibility with formalin-fixed paraffin-embedded (FFPE) ...
Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...
Abstract: Spatial transcriptomics has revolutionized the ability to investigate transcriptional patterns within tissue morphology. However, many ST clustering pipelines operate on a single preselected ...
10x Genomics is re-rated neutral after a 186% rally, with a $30 price target implying limited near-term upside. TXG's fundamentals improved: Q1 gross margin expanded to 70%, GAAP net loss narrowed by ...
Abstract: Spatial transcriptomics enables the study of gene expression within the spatial context of tissues, offering valuable insights into tissue organization and function. However, technical ...
PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the ...
Jeff Carlson writes about mobile technology for CNET. He is also the author of dozens of how-to books covering a wide spectrum ranging from Apple devices and cameras to photo editing software and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results